Skip to main content

Table 1 Distribution of preoperative and operative data in both groups (n = 150)

From: Does prophylactic low-dose amiodarone decrease the incidence of postoperative atrial fibrillation after coronary artery bypass graft surgery? A randomized controlled trial

 

Placebo group (n = 75)

Amiodarone group (n = 75)

P value

Age (years)

57.31 ± 6.85

57.76 ± 5.80

0.663

Gender

Male

45 (60%)

42 (56%)

0.62

Female

30 (40%)

33 (44%)

Hypertension

38 (50.7%)

34 (45.3%)

0.513

DM

34 (45.3%)

45 (60%)

0.072

Smoking

21 (28%)

19 (25.3%)

0.712

CCS > 3

53 (70.7%)

47 (62.7%)

0.299

NYHA > III

26 (34.7%)

24 (32%)

0.729

Previous MI

25 (33.3%)

24 (32%)

0.862

Obesity

9 (12%)

7 (9.3%)

0.597

Preoperative EF (%)

49.63 ± 5.68

51.03 ± 6.53

0.163

Preoperative LA size (%)

3.68 ± 0.32

3.73 ± 0.29

0.317

Operative data

Ischemic time (min)

61.19 ± 9.5

63.85 ± 8.16

0.067

Total bypass time (min)

97.59 ± 9.77

95.89 ± 8.47

0.259

Intraoperative inotropes

48 (64%)

46 (61.3%)

0.736

Number of grafts

2.60 ± 1.15

2.32 ± 0.82

0.089

  1. Data presented as mean ± SD or frequency (%)
  2. DM diabetes mellitus, CCS chronic coronary syndromes, NYHA New York Heart Association, MI myocardial infarction, EF ejection fraction, LA left atrium